Author:
Ghanem Paola,Murray Joseph C.,Hsu Melinda,Guo Matthew Z.,Ettinger David S.,Feliciano Josephine,Forde Patrick,Hann Christine L.,Lam Vincent K.,Levy Benjamin,Anagnostou Valsamo,Brahmer Julie R.,Marrone Kristen A.
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference48 articles.
1. Global Cancer Observatory: Cancer Today;Ferlay,2020
2. Cancer statistics, 2022;Siegel;CA: A Cancer Journal for Clinicians,2022
3. Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial;Mok;Lancet,2019
4. Overall Survival with Osimertinib in Untreated;Ramalingam;N Engl J Med,2020
5. First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer;Shaw;N Engl J Med,2020